Upgrade to SI Premium - Free Trial

Amneal completes acquisition of Kashiv BioSciences

August 10, 2026 8:00 AM
Amneal Pharmaceuticals (NASDAQ: AMRX) announced the completion of its acquisition of Kashiv BioSciences, LLC, combining Kashiv's biologics research, development, and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Mergers and Acquisitions